GH administration and discontinuation in healthy elderly men: effects on body composition, GH‐related serum markers, resting heart rate and resting oxygen uptake
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES GH administration results in increased lean body mass (LBM), decreased fat mass (FM) and increased energy expenditure (EE). GH therapy may therefore have potential benefits, especially in the elderly, who are known to have decreased function of the GH/IGF‐I axis. Several studies have focused on effects of GH administration in the elderly in the last decade. However, very limited information is available regarding changes in body composition and EE upon GH discontinuation in the elderly. The present study therefore investigated the effects of 12 weeks of GH administration and subsequent discontinuation on body composition, resting oxygen uptake (VO 2), resting heart rate (HR) and GH related serum markers in healthy elderly men. SUBJECTS AND METHODS Sixteen healthy men [age 74 ± 1 years (mean ± SEM), height 174·2 ± 1·6 cm, body weight 80·7 ± 2·6 kg, body fat 27·5 ± 1·1%] completed the study protocol. Recombinant human GH (1·80 ± 0·24 IU/day) was administered for 12 weeks in a single‐blinded, placebo‐controlled design. Body composition (dual energy X‐ray absorptiometry), resting VO 2 (indirect calorimetry), resting HR (telemetry) and serum IGF‐I, IGF‐II, IGFBP‐3 and acid labile subunit (ALS) were measured at baseline, after 12 weeks of GH administration and, additionally in the GH group, 1, 2, 3, 4, 5 and 9 days after GH discontinuation. RESULTS Body weight was unchanged from baseline to 12 weeks in both groups. However, GH administration caused a decrease in FM (3·4 ± 1·0 kg, P < 0·012), paralleled by a similar increase in LBM (3·2 ± 0·4 kg, P < 0·0002). Resting VO 2 and resting HR increased by 31 ± 3·6% and 7·3 ± 1·9 per minute, respectively, in the GH‐group, where significant increases in serum IGF‐I, IGFBP‐3 and ALS also were noted. None of the above parameters changed in the placebo group. Within 2–3 days after GH discontinuation, the GH related serum markers and resting HR returned to baseline levels, whereas resting VO 2 remained elevated even 9 days after GH discontinuation. In addition, GH discontinuation caused a significant decrease in body weight (1·86 ± 0·35 kg), derived exclusively from a decrease in LBM (1·63 ± 0·43 kg), while the decreased FM was maintained (12 weeks: 17·93 ± 1·65 kg, +9 days: 17·74 ± 1·62 kg). CONCLUSIONS The increases in serum IGF‐I, IGFBP‐3, ALS and resting heart rate induced by 12 weeks of GH administration in elderly men returned to baseline levels within 2–3 days after GH discontinuation. However, resting VO 2 remained elevated for a longer period. GH administration reduced fat mass but maintained body weight by increasing lean body mass. In contrast, 9 days of GH discontinuation reduced body weight exclusively by reducing lean body mass.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
Human growth hormone and human aging
CORPAS, E., HARMAN, S. M., & BLACKMAN, M. R. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-1-20 · Cited by 911 · cited 1×
“This decline has been proposed to play a causal role in the changes in body composition and resting EE observed in elderly (Rudman et al., 1981; Corpas et al., 1993; Martin et al., 1997).”
BackgroundGrowth Hormone Replacement in Healthy Older Men Improves Body Composition but Not Functional Ability
Papadakis, M. A., Grady, D., Black, D., Tierney, M. J., Gooding, G. A. W., Schambelan, M., & Grunfeld, C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-8-199604150-00002 · Cited by 474
Jørgensen, J. O. L., Møller, J., Laursen, T., Ørskov, H., Christiansen, J. S., & Weeke, J. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb01826.x · Cited by 162
Schrauwen, P., Xia, J., Bogardus, C., Pratley, R. E., & Ravussin, E. (1999) · Diabetes · doi:10.2337/diabetes.48.1.146 · Cited by 129
Cited by
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071
Muscle tissue changes with aging
Volpi, E., Nazemi, R., & Fujita, S. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000134362.76653.b2 · Cited by 569
Systematic review: the safety and efficacy of growth hormone in the healthy elderly
Liu, H., Bravata, D. M., Olkin, I., Nayak, S., Roberts, B., Garber, A. M., & Hoffman, A. R. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00005 · Cited by 370
“, 2002 (36) and 2001 (40)¶ 74 (6) 75 (3) 0 0 8/7 7/7 26 (NA) 27 (NA) 145/247 166/159 12 12.”
BackgroundResultInfluentialHormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Havers, T., Held, S., Schönfelder, M., Geisler, S., & Wackerhage, H. (2025) · Sports Medicine · doi:10.1007/s40279-025-02263-w · Cited by 19
Metadata
- Authors
- Lange, K. H. W., Isaksson, F., Rasmussen, M. H., Juul, A., Bülow, J., & Kjær, M.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2001-07
- Volume
- 55
- Issue
- 1
- Pages
- 77-86
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2162184347
- Cited by
- 36
- References
- 5
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GH administration and discontinuation in healthy elderly men: effects on body composition, GH‐related serum markers, resting heart rate and resting oxygen uptake. https://app.cochat.ai/papers/10.1046/j.1365-2265.2001.01344.x
- The paper
- Lange, K. H. W., Isaksson, F., Rasmussen, M. H., Juul, A., Bülow, J., & Kjær, M. (2001). GH administration and discontinuation in healthy elderly men: effects on body composition, GH‐related serum markers, resting heart rate and resting oxygen uptake. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2001.01344.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.